Heparin-coated Cardiopulmonary Bypass Circuits Reduce Circulating Complement Factors and Interleukin-6 in Paediatric Heart Surgery

Author： Olsson Christian Siegbahn Agneta Henze Axel Nilsson Bo Venge Per Joachimsson Per-Olof Thelin Stefan

Publisher： Informa Healthcare

ISSN： 1401-7431

Source： Scandinavian Cardiovascular Journal, Vol.34, Iss.1, 2000-05, pp. : 33-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Children are sensitive to the inflammatory side effects of cardiopulmonary bypass (CPB). Our intention was to investigate if the biocompatibility benefits of heparin-coated CPB circuits apply to children. In 20 operations, 19 children were randomized to heparin-coated (group HC, n = 10) or standard (group C, n = 10) bypass circuits. Plasma levels of acute phase reactants, interleukins, granulocytic proteins and complement factors were measured. All were significantly elevated after CPB. Levels of complement factor C3a (851 (791-959) ng/ml [median with quartiles] in group C, 497 (476-573) ng/ml in group HC, p < 0.001), Terminal Complement Complex (114 (71-130) AU/ml in group C, 35.5 (28.9-51.4) AU/ml in group HC, p < 0.001), and interleukin-6 (570 (203-743) pg/ml in group C, 168 (111-206) pg/ml in group HC, p = 0.005), were significantly reduced in group HC. Heparin-coated CPB circuits improve the biocompatibility of CPB during heart surgery in the paediatric patient population, as reflected by significantly reduced levels of circulating complement factors and interleukin-6.